Recent developments include the announcement of third quarter 2026 results and earnings call, divestiture of the Diabetes Health unit to Cardinal Health, and ongoing operational updates from earnings calls.

• AdaptHealth announced its third quarter 2026 financial results and held an earnings call providing operational updates [N2][N1].
• The company divested its Diabetes Health unit to Cardinal Health in a $235 million deal to focus more on Sleep and Respiratory growth segments [N8][N7].
• Recent earnings calls for Q2 and Q3 2026 highlighted growth drivers such as the Kaiser deal and discussed labor cost impacts on EBITDA [N4][N1].
• AdaptHealth continues to operate approximately 640 locations servicing 4.3 million patients annually across 48 states [S1].

AdaptHealth's integrated technology platform and centralized operations enable efficient delivery of a broad range of home medical equipment and services, supporting patient care continuity and compliance. The company's diversified revenue streams, including consumables, fixed monthly payments, and capitated arrangements, provide multiple sources of income. Its large patient base and extensive geographic footprint offer scale advantages. The divestiture of the Diabetes Health unit allows sharper focus on Sleep and Respiratory segments, which may align with growth opportunities. Continued deployment of AI and technology innovations could enhance operational efficiencies and patient experience. The company's acquisition strategy supports expansion and integration synergies [S1][N8][N7].

AdaptHealth faces risks from reliance on a limited number of suppliers for critical equipment and supplies, with recent supplier field actions impacting product availability and costs. The company reported a significant net loss and negative earnings per share in the latest quarter, indicating ongoing profitability challenges. The home medical equipment market is highly competitive with pressure from large national providers, regional players, and non-traditional entrants. Extensive regulatory requirements and compliance risks, including privacy laws and reimbursement regulations, pose operational challenges. The divestiture of the Diabetes Health unit reduces diversification. Supply chain disruptions, labor costs, and reimbursement pressures could adversely affect financial performance [S2].

AdaptHealth's competitive advantages include its integrated technology-enabled platform that automates and streamlines patient care delivery and compliance, its broad and comprehensive product offering across multiple home medical equipment categories, and its extensive network of referral sources and payor contracts. The company's scale with approximately 640 locations servicing 4.3 million patients annually provides operational efficiencies and market reach. Its centralized yet locally responsive management structure supports strong relationships with referral sources. The use of proprietary mobile delivery technology and AI tools further differentiates its service quality. These factors collectively contribute to AdaptHealth's ability to compete favorably in a fragmented and competitive home medical equipment market [S1].

• Supplier Concentration Risk: AdaptHealth relies on a relatively small number of suppliers for most patient service equipment and supplies. Disruptions, price increases, or product recalls from these suppliers could impair the company's ability to operate effectively and meet patient demand [S2].
• Regulatory and Compliance Risks: The company operates under extensive federal and state healthcare regulations, including fraud and abuse prevention, reimbursement rules, and privacy laws such as HIPAA and CCPA. Non-compliance could result in penalties, sanctions, or loss of reimbursement eligibility [S1].
• Operational Risks from Supplier Field Actions: In October 2026, Medline Industries initiated a voluntary field action removing certain beds due to safety risks, impacting AdaptHealth's ability to purchase these products and potentially increasing costs and limiting patient supply [S2].
• Profitability and Financial Performance: AdaptHealth reported a net loss of $153.99 million and negative EPS for the quarter ended September 30, 2026, reflecting ongoing challenges in achieving profitability [S2].
• Competitive Market Pressure: The home medical equipment market is fragmented and competitive, with pressure from large national providers, regional companies, product-specific providers, and non-HME entrants such as CVS and Amazon [S1].